|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07H 19/10 | |
| C07H 19/20 | |||
| C07D 473/18 |
| (11) | Number of the document | 2313422 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09763386.1 |
| Date of filing the European patent application | 2009-06-08 | |
| (97) | Date of publication of the European application | 2011-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2015-03-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/046619 |
| Date | 2009-06-08 |
| (87) | Number | WO 2009/152095 |
| Date | 2009-12-17 |
| (30) | Number | Date | Country code |
| 140369 P | 2008-12-23 | US | |
| 479075 | 2009-06-05 | US | |
| 60683 P | 2008-06-11 | US |
| (72) |
DU, Jinfa, US
NAGARATHNAM, Dhanapalan, US
PAMULAPATI, Ganapati, Reddy, US
ROSS, Bruce, S., US
SOFIA, Michael, Joseph, US
|
| (73) |
Gilead Pharmasset LLC,
c/o Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | NUCLEOSIDE CYCLICPHOSPHATES |
| NUCLEOSIDE CYCLICPHOSPHATES |